stella
Condition Guide

New Treatments & Clinical Trials for Knee Osteoarthritis

Last updated June 2026Data from ClinicalTrials.gov817 active trials
← Browse all Knee Osteoarthritis trials

Knee osteoarthritis affects more than 14 million Americans, causing pain, stiffness, and loss of cartilage in the knee joint. Current treatment includes weight loss, physical therapy, pain relievers, corticosteroid injections, and eventually joint replacement for severe cases. Research is now focused on drugs that might slow or reverse cartilage breakdown rather than just managing symptoms.

What's actually going on in research

Trials are testing drugs that target inflammation pathways in the joint, inject growth factors or stem cells to rebuild cartilage, and modify how joint cells respond to injury. Researchers are also studying pain mechanisms to develop better treatments for the chronic pain that persists even after inflammation settles. Gene therapy and cartilage repair techniques are moving from lab to early human trials.

Disease-modifying drugs

Several drugs aim to slow cartilage breakdown by blocking specific inflammatory proteins like nerve growth factor or IL-1. If successful, they could delay or prevent the need for joint replacement.

Regenerative treatments

Trials are testing platelet-rich plasma, stem cell injections, and cartilage repair scaffolds to help the joint rebuild damaged tissue. Some use a person's own cells, while others use engineered materials.

Pain modulation

Researchers are studying why pain persists in osteoarthritis even when inflammation is controlled. New drugs target nerve sensitization and brain pain processing rather than the joint itself.

What to know before you search

Eligibility typically depends on X-ray or MRI evidence of cartilage loss, pain severity, knee function scores, and whether you've tried standard treatments like physical therapy or injections.

What types of trials are currently open

  • Disease-modifying trialsTesting drugs that aim to slow cartilage loss, measured by MRI scans and pain scores over months to years.
  • Injection trialsTesting stem cells, growth factors, or engineered substances injected directly into the knee to rebuild or protect cartilage.
  • Pain treatment trialsTesting new oral or topical medications for knee pain, often compared to standard pain relievers.
  • Device and procedure trialsTesting knee braces, nerve stimulation devices, or minimally invasive procedures to reduce pain or improve function.
  • Lifestyle intervention trialsStudies of exercise programs, weight loss approaches, or dietary changes to see if they slow disease progression.

Recently added Knee Osteoarthritis trials

RecruitingInterventional study

Study of Wearable Interventions for Improving Mobility of Individuals With Knee Osteoarthritis

Knee osteoarthritis (OA) affects an estimated 654 million people over age 40 world-wide. In the United States, approximately 16% of adults over the age of 40 have knee OA. Pain, activity limitations and disability are common symptoms. Exercise is widely recommended as a non-invasive, first line strategy for people with knee OA. Yet, less than 1/3 of adults with knee OA meet recommended levels of physical activity, and rates are even lower among people who are overweight. Furthermore, adherence to evidence-based structured programs is poor once the therapeutic support is removed. End stage disease is treated by total joint replacement. Under-active people with knee OA would benefit from general walking activity, even if joint replacement surgery is expected; however, walking is difficult and motivation is low. Thus, people with knee OA encounter a difficult paradox: exercise could help decrease pain and improve function but doing so can be difficult and may not always be possible. There is a tremendous need to address this situation. This is a small device-feasibility study evaluating the Dephy ExoBoot, a wearable powered exoskeleton, in individuals with knee OA. The study assesses whether the device can reliably deliver positive assistance during walking and is tolerated across walking tasks. Additional measures, including changes in knee loading and walking speed with versus without the device, are also collected.

Cambridge, Massachusetts, United States
RecruitingInterventional study

Perturbation Based Balance Training Versus Progressive Neuromuscular Training as an Adjunct to Conventional Physiotherapy for Pain Reduction and Functional Improvement in Knee Osteoarthritis

This is an RCT aims to explore Perturbation-Based Balance Training versus Progressive Neuromuscular Training as an Adjunct to Conventional Physiotherapy for Pain Reduction and Functional Improvement in Knee Osteoarthritis.

Islamabad, ICT, Pakistan
See all recruiting Knee Osteoarthritis trials →

Find Knee Osteoarthritis trials matched specifically to you

Answer 3 quick questions and we'll show you trials that fit your situation.

Get matched →